Biosyntech

What Biosyntech does

Biosyntech is a privately held Canadian biotherapeutics company headquartered in Laval, Quebec, founded in 1994. The firm specializes in the development of biotherapeutic thermogels—temperature-responsive polymer systems designed for tissue repair and the controlled delivery of therapeutic agents. Its product strategy sits at the intersection of regenerative medicine and drug-delivery technology, targeting clinical applications where injectable or implantable gel matrices can support tissue regeneration or sustained local release of biologics/small molecules.

The company operates at a small scale, with 11-50 employees according to available firmographic data, consistent with a development-stage or early-commercial life-sciences firm. Capital formation has been modest and infrequent: an early-stage BDC Venture Capital investment in 2002, followed by a $1.4 million syndicated round in August 2009 led by a group of life-sciences-focused investors including Fonds de solidarité FTQ, Highland Capital Partners, Pappas Ventures, and ProQuest Investments. No subsequent financing rounds, partnerships, or commercial milestones are documented in the input data, and no customer, pricing, or revenue disclosures are publicly available.

The current biosyntech.com domain resolves to an unrelated Norwegian industrial-biotech entity (Biosyntech AS) focused on protein production from forestry, aquaculture, and livestock—a data conflict that does not appear to describe the Canadian biotherapeutic firm. Biosyntech's business model, pricing mechanics, and downstream customer relationships are not disclosed in the available sources, leaving the commercial path to revenue (licensing, partnership, or direct commercialization) undefined from the input data.

Name

Biosyntech

Legal name

Biosyntech AS

Website

https://biosyntech.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Biosyntech is a privately held Canadian biotherapeutics company, founded in 1994 in Laval, Quebec, developing proprietary thermogel platforms for tissue repair and therapeutic agent delivery in regenerative-medicine applications.

Ownership category

akta.pro rank

Product category

Industrial Biotechnology

NAICS

Animal Food Manufacturing (31111), Grain and Oilseed Milling (3112)

SIC

Food And Kindred Products (2000), Agricultural Production-Crops (100)

akta.pro primary industry

Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation) (AFAJAHAH)

akta.pro secondary industries

Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins) (AFAJAHAL), Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast) (EUAAAIAI), Functional Protein Fractions (Albumins/Globulins, Protein Fibers) (AFAJAHAK)

Keywords

• Industrial protein production
• Aquaculture protein systems
• Forest-derived proteins
• Livestock protein feed
• Biotech protein extraction

Headquarters

HQ city

Laval

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Core offering

Biosyntech AS operates an industrial protein production system that sources proteins from renewable biological origins, including forests, salmon, and livestock. The company provides a web platform with a user dashboard for management and monitoring, and an e-commerce shop (powered by Odoo) for direct product purchases.

Product overview

Biosyntech AS operates as an industrial biotechnology company offering an industrial protein production system. The core offering consists of the Industrial System focused on extracting and producing proteins from renewable biological sources including forests (wood/protein), salmon, and livestock. The platform includes a Dashboard for user management and monitoring, and a Shop for product purchasing powered by Odoo. The company positions itself in the industrial biotechnology space serving the aquaculture (salmon), livestock, and forestry sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• Industrial Protein Production System An industrial protein production system that produces proteins derived from forests, salmon, and livestock for industrial buyers in the aquaculture, livestock, and forestry sectors.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Emerging players

• String Bio: String Bio converts methane into single-cell protein (ProH) for animal feed using gas fermentation. Comparable in microbial protein / industrial biotech serving feed industry.
• NovoNutrients: NovoNutrients produces protein from industrial CO2 emissions using hydrogen-oxidizing bacteria for aquaculture and livestock feed. Comparable in fermentation-based alternative protein for feed markets.
• AgriProtein: AgriProtein produces insect-based protein (MagMeal) from organic waste for animal feed. Comparable as a circular-economy alternative-protein business targeting livestock and aquaculture feed.
• Deep Branch Biotechnology: Deep Branch uses gas fermentation to convert CO2 and hydrogen into single-cell protein (Proton) for animal feed. Comparable industrial biotech alternative-protein platform targeting feed markets.
• Terviva: Terviva produces protein from pongamia seeds for food and feed applications. Comparable in novel plant/non-traditional source protein extraction for industrial applications, though serves different geographies.
• KnipBio: KnipBio produces single-cell protein from methanol for aquaculture feed, with focus on salmon. Comparable end market (salmon feed) and similar alternative-protein technology approach, though smaller and earlier stage.

Direct peers

• Arbiom: Arbiom develops SylPro, a single-cell protein produced from wood-derived biomass (forestry byproducts) for use in aquaculture and livestock feed. Most direct comparable to Biosyntech because both convert forestry/sawmill residues into feed-grade protein using industrial biotechnology.
• Calysta: Calysta produces FeedKind protein via gas fermentation for aquaculture and livestock feed markets. Comparable because it serves the same salmon/livestock feed buyers with alternative protein and follows an industrial biotechnology manufacturing model.

Broad incumbents

• Corbion: Corbion is an established industrial biotech company with operations in algae-based proteins, food ingredients, and animal nutrition. Comparable in industrial biotech + feed/food ingredient positioning, but with much broader portfolio and global scale.

Regional players

• Biomega Group: Biomega (Norway) produces salmon-derived protein hydrolysates and peptides for food, pet food, and aquaculture. Highly relevant as a regional player in Norway with direct overlap in salmon-protein valorization, though focused on extraction rather than fermentation.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/biosyntech

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biosyntech